Literature DB >> 26386477

The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.

Jing Han1, Yubo Liu1, Feng Han1, Qing Li1, Cuiju Yan1, Wei Zheng1, Jianwei Wang1, Zhixing Guo1, Jun Wang1, Anhua Li1, Jianhua Zhou2.   

Abstract

We aim to assess the role and degree of contrast washout in the differential diagnosis of intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) on contrast-enhanced ultrasound (CEUS). Fifty-six histopathology-confirmed ICC nodules and 184 HCC nodules were included in this study. The nodules' washout degree on CEUS at 1, 2 and 3 min was semi-quantitatively and qualitatively assessed using gray-scale video signal intensity. Semi-quantitative assessment showed that the washout degree of ICCs at 1, 2 and 3 min were significantly lower than those of HCCs (p < 0.001) and similar results were found in the same size range subgroups. There were no significant differences in the washout degree of ICCs between patients with chronic hepatitis and those without. The areas under receiver operating characteristic curves, using the nodules' washout degree at 1, 2 and 3 min to differentiate ICC from HCC, were 0.957, 0.979 and 0.982, respectively. The qualitative assessment showed the washout of ICCs was more rapid and obvious than that of HCCs. At 3 min, moderate and marked washout were observed in all ICCs, but in only 12.5% HCCs (p < 0.001). In conclusion, ICCs displayed much higher degree of contrast washout than HCCs on CEUS, which allowed for differentiation from HCCs.
Copyright © 2015 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Differential diagnosis; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Washout

Mesh:

Substances:

Year:  2015        PMID: 26386477     DOI: 10.1016/j.ultrasmedbio.2015.08.001

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  13 in total

1.  Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.

Authors:  Fei Li; Qing Li; Yubo Liu; Jing Han; Wei Zheng; Yini Huang; Xueyi Zheng; Longhui Cao; Jian-Hua Zhou
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

2.  Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group.

Authors:  Andrej Lyshchik; Yuko Kono; Christoph F Dietrich; Hyun-Jung Jang; Tae Kyoung Kim; Fabio Piscaglia; Alexander Vezeridis; Juergen K Willmann; Stephanie R Wilson
Journal:  Abdom Radiol (NY)       Date:  2018-04

3.  Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Xiao-Wen Huang; Yang Huang; Li-da Chen; Zhu Wang; Zheng Yang; Jin-Ya Liu; Xiao-Yan Xie; Ming-De Lu; Shun-Li Shen; Wei Wang
Journal:  J Med Ultrason (2001)       Date:  2017-10-20       Impact factor: 1.314

4.  Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.

Authors:  Juanjuan Zhang; Yanyan Yu; Ying Li; Lunshou Wei
Journal:  Oncotarget       Date:  2017-08-07

Review 5.  Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.

Authors:  Tae Kyoung Kim; Seung Yeon Noh; Stephanie R Wilson; Yuko Kono; Fabio Piscaglia; Hyun-Jung Jang; Andrej Lyshchik; Christoph F Dietrich; Juergen K Willmann; Alexander Vezeridis; Claude B Sirlin
Journal:  Clin Mol Hepatol       Date:  2017-09-15

6.  Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.

Authors:  Li-Da Chen; Si-Min Ruan; Jin-Yu Liang; Zheng Yang; Shun-Li Shen; Yang Huang; Wei Li; Zhu Wang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Wei Wang
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

Review 7.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06

Review 8.  Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.

Authors:  Junghoan Park; Jeong Min Lee; Tae-Hyung Kim; Jeong Hee Yoon
Journal:  Clin Mol Hepatol       Date:  2021-12-27

9.  Contrast-Enhanced Ultrasound Improves the Pathological Outcomes of US-Guided Core Needle Biopsy That Targets the Viable Area of Anterior Mediastinal Masses.

Authors:  Jian-Hua Zhou; Hong-Bo Shan; Wei Ou; Yun-Xian Mo; Jin Xiang; Yu Wang; Jian Li; Si-Yu Wang
Journal:  Biomed Res Int       Date:  2018-01-18       Impact factor: 3.411

10.  Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?

Authors:  Jia-Yan Huang; Jia-Wu Li; Wen-Wu Ling; Tao Li; Yan Luo; Ji-Bin Liu; Qiang Lu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.